Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exposed dentin tubules are microscopic, fluid-filled channels that traverse the dentin layer of the tooth, connecting the dental pulp to the outer layers of enamel or cementum (StatPearls, 2023). Under normal physiological conditions, these tubules are protected by enamel in the crown and cementum in the root; however, they can become exposed to the oral environment due to gingival recession, acid erosion, or mechanical wear (PubMed, PMID: 16355646). This exposure is the fundamental anatomical cause of dentin hypersensitivity, as it allows external thermal, osmotic, or tactile stimuli to trigger fluid movement within the tubules. According to the hydrodynamic theory, this fluid movement activates mechanoreceptors in the dental pulp, resulting in sharp, transient pain (Brännström, 1963). Clinical treatments for this condition focus on either reducing the excitability of the intradental nerves using potassium salts or, more commonly, occluding the tubule openings with mineralizing agents like fluoride or arginine to prevent fluid flow (NIH, 2021). While not a molecular target in the traditional pharmacological sense, these structures are the primary focus of desensitizing dental therapies.
Therapeutic agents target exposed dentin tubules through two primary mechanisms: nerve desensitization and tubule occlusion. Nerve desensitizers, such as potassium nitrate, increase extracellular potassium ion concentration to depolarize nerve membranes and inhibit pain signal transmission (StatPearls, 2023). Occluding agents, including stannous fluoride, oxalates, and arginine-calcium carbonate complexes, physically block the tubule orifices to prevent the movement of dentinal fluid induced by external stimuli, thereby halting the hydrodynamic mechanism of pain (PubMed, PMID: 16355646).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exposed dentin tubules.